<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01510938</url>
  </required_header>
  <id_info>
    <org_study_id>SG-11009</org_study_id>
    <nct_id>NCT01510938</nct_id>
  </id_info>
  <brief_title>Probiotics in Respiratory Tract Infections in Children</brief_title>
  <official_title>Role of Probiotics in Prevention of Respiratory Tract Infections in Preschool and Primary School Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lviv National Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Lviv National Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the potential of probiotics in prevention of
      respiratory tract infections and their complications in children
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">May 2012</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of respiratory tract infection episodes in a child</measure>
    <time_frame>1 month</time_frame>
    <description>An episode will be defined as display of fever, cough, rhinitis, and sore throat or combination thereof for longer than 48 hours</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration of respiratory tract infection</measure>
    <time_frame>21 days</time_frame>
    <description>Time to CARIFS (Canadian Acute Respiratory Illness and Flu Scale) value 0</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Severity of respiratory tract infection</measure>
    <time_frame>21 days</time_frame>
    <description>a product of daily CARIFS times the duration of the disease</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications of respiratory tract infections</measure>
    <time_frame>21 days</time_frame>
    <description>Percent of otitis, sinusitis, bronchitis, pneumonia cases</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Antibiotic prescriptions</measure>
    <time_frame>21 days</time_frame>
    <description>Percent</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospitalization rate</measure>
    <time_frame>21 days</time_frame>
    <description>Number of hospitalizations</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of unscheduled doctor visits</measure>
    <time_frame>21 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of days daycare/school missed</measure>
    <time_frame>21 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of workdays missed by parents</measure>
    <time_frame>21 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to resolution of individual CARIFS item</measure>
    <time_frame>21</time_frame>
    <description>Days to the correspondent CARIFS item 0</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>25% and 50% decrease in the CARIFS score</measure>
    <time_frame>21day</time_frame>
    <description>25% and 50% decrease in the CARIFS score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percent and duration of the use of over-the-counter medications</measure>
    <time_frame>21day</time_frame>
    <description>Percent and duration of the use of over-the-counter medications</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">242</enrollment>
  <condition>Infections, Respiratory Tract</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>1 g of rice maltodextrin will be reconstituted in 25-50 ml of tepid water or juice and immediately fed once a day for 2-weeks trial period or to the end of acute respiratory infection depending on whatever is longer.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Probiotic</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>powder of L. acidophilus DDS-1, B. lactis UABLA-12, 50 mg of fructooligosaccharide
1 g of probiotic will be reconstituted in 25-50 ml tepid water or juice and immediately fed once a day (5 billion CFU/daily) for 2-weeks trial period or to the end of acute respiratory infection depending on whatever is longer.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>L. acidophilus DDS-1, B. lactis UABLA-12</intervention_name>
    <description>1 g of probiotic will be reconstituted in 25-50 ml tepid water, juice or age specific baby food and immediately fed once a day (5 billion CFU/daily) for 2-weeks trial period or to the end of acute respiratory infection depending on whatever is longer.</description>
    <arm_group_label>Probiotic</arm_group_label>
    <other_name>DDS-Junior</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>1 g in 25-50 ml of tepid water or juice fed once a day for 2-weeks trial period or to the end of acute respiratory infection depending on whatever is longer.</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Rice maltodextrin</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 3-12 yrs

          -  At least one episode of respiratory tract infection in the previous epidemiological
             season

          -  Direct telephone access available

          -  Informed consent signed

        Exclusion Criteria:

          -  Vaccination against the influenza

          -  Chronic adeno-tonsillar pathology

          -  Recurrent otitis

          -  Sinusitis

          -  Respiratory allergy

          -  Acute or chronic intestinal disease with diarrhea and/or malabsorption syndrome

          -  Lactose intolerance

          -  Functional or organic constipation

          -  Down syndrome

          -  Congenital or acquired heart disease

          -  Cerebral palsy

          -  Any chronic hepatic, renal, metabolic, or immune system disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sergei V Gerasimov, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lviv National Medical University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Lviv City Children Hospital</name>
      <address>
        <city>Lviv</city>
        <zip>79059</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Ukraine</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 12, 2012</study_first_submitted>
  <study_first_submitted_qc>January 17, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 18, 2012</study_first_posted>
  <last_update_submitted>December 25, 2013</last_update_submitted>
  <last_update_submitted_qc>December 25, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 30, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Lviv National Medical University</investigator_affiliation>
    <investigator_full_name>Sergei V. Gerasimov, MD, PhD</investigator_full_name>
    <investigator_title>Associate Professor of Pediatrics</investigator_title>
  </responsible_party>
  <keyword>Children</keyword>
  <keyword>Respiratory Tract Infections</keyword>
  <keyword>Prevention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Respiratory Tract Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

